TITLE

Review: Antileukotriene agents at licensed doses plus inhaled corticosteroids do not reduce asthma exacerbations more than inhaled corticosteroids alone

PUB. DATE
November 2004
SOURCE
ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p73
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article addresses the question whether adding antileukotriene (AL) agents to inhaled corticosteroids (ICSs) reduces exacerbations and improve asthma control more than ICSs alone in patients with chronic asthma.It also addresses the question whether ALs allow a reduction in ICS dose.The article adds that In patients with chronic asthma, adding antileukotriene (AL) agents at licensed doses to inhaled corticosteroids does not reduce exacerbations and only modestly improves asthma control. At higher-than-licensed doses, ALs reduce exacerbations.
ACCESSION #
15303596

 

Related Articles

  • COMMENTARY: Antileukotriene agents at licensed doses plus inhaled corticosteroids do not reduce asthma exacerbations more than inhaled corticosteroids alone. Rees, P. John // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p73 

    The article presents a commentary on the study, which concluded that antileukotriene (AL) agents at licensed doses plus inhaled corticosteroids (ICS) do not reduce asthma exacerbations more than inhaled corticosteroids alone. In 2002, a commentary on the Cochrane review of ALs in patients with...

  • Daily corticosteroids were not better than as-needed corticosteroids in mild persistent asthma.  // ACP Journal Club;Nov/Dec2005, Vol. 143 Issue 3, p60 

    This article presents information on a clinical study according to which daily corticosteroids were not better than as-needed corticosteroids in mild persistent asthma. This study explored that in patients with mild persistent asthma, how does intermittent, short-course corticosteroid treatment...

  • Initial starting dose inhaled corticosteroids in adults with asthma: a systematic review. Powell, S. H.; Gibson, P. G. // Thorax;Dec2004, Vol. 59 Issue 12, p1041 

    Background: Asthma guidelines vary in their recommendations for the initial dose of inhaled corticosteroid (ICS) in asthma. A systematic review of the literature was conducted to establish the optimal starting dose of ICS for asthma in adults. Methods: Randomised controlled trials comparing two...

  • Review: Adults who require inhaled corticosteroids benefits from a moderate starting dose.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p72 

    The article addresses the question as to what is the optimum starting dose in patients with asthma not treated by inhaled corticosteroids (ICSs). The article adds that In patients with asthma who require inhaled corticosteroids, an initial high dose improves FEV but does not differ from moderate...

  • Daily corticosteroids were not better than as-needed corticosteroids in mild persistent asthma: COMMENTARY. Ramey, John T.; Ledford, Dennis // ACP Journal Club;Nov/Dec2005, Vol. 143 Issue 3, p60 

    This article comments on a clinical study in which daily corticosteroids were not better than as-needed corticosteroids in mild persistent asthma. The use of as-needed inhaled corticosteroids (ICSs) eventually may be shown to be an alternative in the treatment of mild persistent asthma, but...

  • Bronchial Asthma -- Patient Expectations and the Role in Asthma Care. Scott, P. // West Indian Medical Journal;Jun2009, Vol. 58 Issue 3, p193 

    The author reflects on the progress in treatment bronchial asthma. The author says that the focus on asthma care has transformed from solely focusing on symptom relief to a result-driven philosophy. The author notes that the use of inhaled corticosteroids has remained significantly below the...

  • Validity of performance indicators for assessing prescribing quality: the case of asthma. Pont, Lisa G.; Denig, Petra; van der Molen, Thys; van der Veen, Willem Jan; Haaijer-Ruskamp, Flora M. // European Journal of Clinical Pharmacology;Jan2004, Vol. 59 Issue 11, p833 

    Objectives. The aim of this study was to assess the concurrent validity between the identification of sub-optimal treatment based on clinical information and computer generated indicators. Indicators that are associated with sub-optimal treatment in one of the four steps of asthma management...

  • Acute asthma. FitzGerald, Mark // BMJ: British Medical Journal (International Edition);10/13/2001, Vol. 323 Issue 7317, p841 

    Aetiology/risk factors Most people with asthma are atopic; exposure to certain stimuli initiates inflammation and structural changes in airways, causing airway hyperresponsiveness and variable airflow obstruction, which in turn cause most asthma symptoms. Stimuli include environmental...

  • Comparison of Physician-, Biomarker-r and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma. Calhoun, William J.; Ameredes, Bill T.; King, Tonya S.; Icitovic, Nikolina; Bleecker, Eugene R.; Castro, Mario; Cherniack, Reuben M.; Chinchilli, Vernon M.; Craig, Timothy; Denlinger, Loren; DiMango, Emily A.; Engle, Linda L.; Fahy, John V.; Grant, J. Andrew; Israel, Elliot; Jarjour, Nizar; Kazani, Shamsah D.; Kraft, Monica; Kunselman, Susan J.; Lazarus, Stephen C. // JAMA: Journal of the American Medical Association;9/12/2012, Vol. 308 Issue 10, p987 

    The article presents a randomized clinical trial, Best Adjustment Strategy for Asthma in the Long Term (BASALT) to determine the adjustments of inhaled corticosteroid therapy in preventing treatment failure in adults with mild to moderate asthma. The study concluded that the adults with mild to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics